Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants.
We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment.
Hageman
Jeffrey C
JC
Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA. jhageman@cdc.gov
Liedtke
Laura A
LA
Sunenshine
Rebecca H
RH
Strausbaugh
Larry J
LJ
McDonald
L Clifford
LC
Tenover
Fred C
FC
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy*; D003625:Data Collection; D006801:Humans; D016357:Infection Control Practitioners; D016106:Methicillin Resistance; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents